Intuitive Venture Partners | Venture Capital Firms NYC | Investment Bank New York City
Transactions News Contact Login
The FIRM Testimonials
Managing Partners Business Relationships
Investment Banking Services Proprietary Investment Opportunities
About The FIRM Testimonials Team Managing Partners Business Relationships Services Investment Banking Services Proprietary Investment Opportunities TransactionsNewsContactLogin
Intuitive Venture Partners | Venture Capital Firms NYC | Investment Bank New York City
Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial
pharmaceuticalIntuitive Venture PartnersSeptember 4, 2018pieris, 2018
Facebook0 Twitter LinkedIn0 Reddit Tumblr 0 Likes
Previous

Neurotrope Enters into Collaboration with the Nemours / Alfred I. duPont Hospital for Children to Initiate a Clinical Trial in Fragile X Syndrome

pharmaceutical, alzheimersIntuitive Venture PartnersSeptember 5, 2018neurotrope, 2018
Next

Entera Bio Reports Second Quarter 2018 Financial Results and Operating Update

pharmaceuticalIntuitive Venture PartnersAugust 20, 2018entera bio, 2018

Intuitive Venture Partners, LLC. • 777 Westchester Ave, Suite 101 • White Plains, NY 10604

Intuitive Venture Partners
777 Westchester Avenue,
White Plains, NY, 10604,
United States
212-612-3221 info@intuitivevp.com
Hours
Mon 8am - 5pm
Tue 8am - 5pm
Wed 8am - 5pm
Thu 8am - 5pm
Fri 8am - 5pm
 

2023 INTUITIVE VENTURE PARTNERS, LLC. ALL RIGHTS RESERVED. SECURITIES OFFERED THROUGH
NETWORK 1 FINANCIAL SECURITIES, INC., A REGISTERED BROKER-DEALER, MEMBER FINRA AND SIPC

broker-check-sml.png
Terms of UseContact